Stanley Druckenmiller acquired 16M Teva- Pharmaceutical Industries Ltd. shares worth $300M. That's 7.53% of their entire equity portfolio (3rd largest holding). The investor owns 1.42% of the outstanding Teva- Pharmaceutical Industries Ltd. stock. The first Teva- Pharmaceutical Industries Ltd. trade was made in Q4 2013. Since then Stanley Druckenmiller bought shares five more times and sold shares on two occasions. The stake costed the investor $287M, netting the investor a gain of 4.5% so far.